Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extraocular muscle stem cells exhibit distinct cellular properties associated with non-muscle molecular signatures. | Development | 2024 | 38240380 | PubTator, text mining | PubMed |
| CKLF1, transcriptionally activated by FOXC1, promotes hypoxia/reoxygenation‑induced oxidative stress and inflammation in H9c2 cells by NLRP3 inflammasome activation. | Exp Ther Med | 2024 | 38234613 | PubTator, text mining | PubMed |
| Complex balanced intrachromosomal rearrangement involving PITX2 identified as a cause of Axenfeld-Rieger Syndrome. | Am J Med Genet A | 2024 | 38234180 | PubTator, text mining | PubMed |
| TSCRE: a comprehensive database for tumor-specific cis-regulatory elements. | NAR Cancer | 2024 | 38213995 | PubTator, text mining | PubMed |
| HCC-Related lncRNAs: Roles and Mechanisms. | Int J Mol Sci | 2024 | 38203767 | PubTator, text mining | PubMed |
| Potential diagnostic markers and therapeutic targets for periodontitis and Alzheimer's disease based on bioinformatics analysis. | J Periodontal Res | 2024 | 38189472 | PubTator, text mining | PubMed |
| The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review). | Int J Oncol | 2024 | 38186313 | PubTator, text mining | PubMed |
| Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression. | Breast Cancer Res Treat | 2024 | 38183514 | PubTator, text mining | PubMed |
| Promotion effect of FOXCUT as a microRNA sponge for miR-24-3p on progression in triple-negative breast cancer through the p38 MAPK signaling pathway. | Chin Med J (Engl) | 2024 | 38178324 | PubTator, text mining | PubMed |
| The single-cell transcriptomic atlas and RORA-mediated 3D epigenomic remodeling in driving corneal epithelial differentiation. | Nat Commun | 2024 | 38177186 | PubTator, text mining | PubMed |
| In vivo identification of angle dysgenesis and its relation to genetic markers associated with glaucoma using artificial intelligence. | Indian J Ophthalmol | 2024 | 38146977 | PubTator, text mining | PubMed |
| Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review). | Oncol Rep | 2024 | 38131215 | PubTator, text mining | PubMed |
| Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance. | Gene | 2024 | 38101711 | PubTator, text mining | PubMed |
| Mechanisms and functions of intestinal vascular specialization. | J Exp Med | 2024 | 38051275 | PubTator, text mining | PubMed |
| Short-read whole genome sequencing identifies causative variants in most individuals with previously unexplained aniridia. | J Med Genet | 2024 | 38050128 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Extraction of characteristic serum microRNAs and prediction of target genes in IgG4-related dacryoadenitis and sialadenitis. | Mod Rheumatol | 2024 | 37747366 | PubTator, text mining | PubMed |
| Prognostic and clinical value of circPRKCI expression in diverse human cancers. | Chin Med J (Engl) | 2024 | 37718264 | PubTator, text mining | PubMed |
| Bioactive materials for in vivo sweat gland regeneration. | Bioact Mater | 2024 | 37637080 | PubTator, text mining | PubMed |
| Ocular manifestations of congenital anomalies of the kidney and urinary tract (CAKUT). | Pediatr Nephrol | 2024 | 37468646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=14